CA4 and cancer: The top three drugs with the largest number of interactions are dasatinib, quercetin and nilotinib (Table 2 in Figure 5C), the top three actionable targets with the largest number of potential drugs are CA1, CA4 and FLT3 (Table 3 in Figure 5C), and the top three actionable pathway terms are pathways in cancer, nitrogen metabolism and osteoclast differentiation (Table 4 in Figure 5C).